Notch-1 inhibits apoptosis in murine erythroleukemia cells and is necessary for differentiation induced by hybrid polar compounds

Journal of Cellular Biochemistry

Volumn 73, Issue 2, 1999, Pages 164-175

  Shelly, Leslie L ^a   Fuchs, Chana ^a   Miele, Lucio ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cancer; Differentiation inducing drugs; Notch 1

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; HEXAMETHYLENEBISACETAMIDE; MEMBRANE RECEPTOR; MESSENGER RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; ERYTHROLEUKEMIA CELL; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACETAMIDES; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; CLONE CELLS; DOWN-REGULATION; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MEMBRANE PROTEINS; MICE; OLIGONUCLEOTIDES, ANTISENSE; RECEPTOR, NOTCH1; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033135914     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990501)73:2<164::AID-JCB3>3.0.CO;2-0     Document Type: Article

References (40)

1. Andreef M, Stone R, Michaeli J, Young CW, Tong W, Sogoloff H, Ervin T, Kufe D, Rifkind RA, Marks PA. 1992. Hexamethylene bisacetamide in myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML): A phase II clinical trial with a differentiation-inducing agent. Blood 80:2604-2609.
2. Artavanis-Tsakonas S, Matsuno K, Fortini ME. 1995. Notch signaling. Science 268:225-232.
3. Aster J, Pear W, Hasserjian R, Erba H, Davi F, Luo B, Scott M, Baltimore D, Sklar J. 1994. Functional analysis of the TAN-1 gene, a human homolog of Drosophila notch. Cold Spring Harb Symp Quant Biol 59:125-136.
4. Austin CP, Feldman DE, Ida JA, Jr, Cepko CL. 1995. Vertebrate retinal ganglion cells are selected from competent progenitors by the action of Notch. Development 121:3637-3650.
5. Ben-David Y, BernsteinA. 1991. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 66:831-834.
6. Bettenhausen B, de Angelis MH, Simon D, Guenet JL, Gossler A. 1995. Transient and restricted expression during mouse embryogenesis of Dill, a murine gene closely related to Drosophila Delta. Development 121:2407-2418.
7. Blaumueller CM, Artavanis-Tsakonas S. 1997. Comparative aspects of Notch signaling in lower and higher eukaryotes [In Process Citation]. Perspect Dev Neurobiol 4:325-343.
8. Blaumueller CM, Qi H, Zagouras P, Artavanis-Tsakonas S. 1997. Intracellular cleavage of notch leads to a heterodimeric receptor on the plasma membrane. Cell 90:281-291.
9. Capobianco AJ, Zagouras P, Blaumueller CM, Artavanis-Tsakonas S, Bishop JM. 1997. Neoplastic transformation by truncated alleles of human NOTCH 1/TAN1 and NOTCH2. Mol Cell Biol 17:6265-6273.
10. Daniel B, Rangarajan A, Mukherjee G, Vallikad E, Krishna S. 1997. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J GenVirol 78:1095-1101.
11. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, Sklar J. 1991. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66:649-661.
12. Fibach E, Reuben RC, Rifkind RA, Marks PA. 1977. Effect of hexamethylene bisacetamid on the commitment to differentiation in murine erythroleukemia cells. Cancer Res 37:440-444.
13. Garces C, Ruiz-Hidalgo MJ, Font de Mora J, Park C, Miele L, Goldstein J, Bonvini E, Porras A, Laborda J. 1997. Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. J Biol Chem 272:29729-29734.
14. Greenwald I. 1998. LIN-12/Notch signaling: Lessons from worms and flies. Genes Dev 12:1751-1762.
15. Guan E, Wang J, Laborda J, Norcross M, Baeuerle PA, Hoffman T. 1996. T cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells. J Exp Med 183:2025-2032.
16. Hollstein M, Sidransky D, Vogelstein B, Harris CC. 1991. p53 mutations in human cancers. Science 253:49-53.
17. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A. 1995. Signalling downstream of activated mammalian Notch [see comments]. Nature 377:355-358.
18. Kiyokawa H, Richon VM, Rifkind RA, Marks PA. 1994. Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol Cell Biol 14:7195-7203.
19. Kiyokawa H, Richon VM, Venta-Perez G, Rifkind RA, Marks PA. 1993. Hexamethylenebisacetamide-induced erythro-leukemia cell differentiation involves modulation of events required for cell cycle progression through G1. Proc Natl Acad Sci USA 90:6746-6750.
20. Kopan R, Nye JS, Weintraub H. 1994. The intracellular domain of mouse Notch: A constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. Development 120:2385-2396.
21. Kopan R, Schroeter EH, Weintraub H, Nye JS. 1996. Signal transduction by activated mNotch: Importance of proteolytic processing and its regulation by the extracellular domain. Proc Natl Acad Sci USA 93:1683-1688.
22. Marks PA, Richon VM, Kiyokawa H, Rifkind RA. 1994. Inducing differentiation of transformed cells with hybrid polar compounds: A cell cycle-dependent process. Proc Natl Acad Sci USA 91:10251-10254.
23. Marks PA, Richon VM, Rifkind RA. 1996. Cell cycle regulatory proteins are targets for induced differentiation of transformed cells: Molecular and clinical studies employing hybrid polar compounds. Int J Hematol 63:1-17.
24. Milner LA, Bigas A, Kopan R, Brashem-Stein C, Bernstein ID, Martin DI. 1996. Inhibition of granulocytic differentiation by mNotch1. Proc Natl Acad Sci USA 93:13014-13019.
25. Morgenstern JP, Land H. 1990. Advanced mammalian gene transfer: High titer retroviral vectors with multiple drug selection markers and a complementary, helper-free packaging cell lines. Nucleic Acids Res 18:3587-3596.
26. Ordentlich P, Lin A, Shen CP, Blaumueller C, Matsuno K, Artavanis-Tsakonas S, KadeschT. 1998. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol Cell Biol 18:2230-2239.
27. Orkin SH, Harosi FI, Leder P. 1975. Differentiation in erythroleukemic cells and their somatic hybrids. Proc Natl Acad Sci USA 72:98-102.
28. Oswald F, Liptay S, Adler G, Schmid RM. 1998. NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol Cell Biol 18:2077-2088.
29. Pear WS, Aster JC, Scott ML, Hasserjian RP, Soffer B, Sklar J, Baltimore D. 1996. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 183:2283-2291.
30. Robey E, Chang D, Itano A, Cado D, Alexander H, Lans D, Weinmaster G, Salmon P. 1996. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell 87:483-492.
31. Ryan JJ, Danish R, Gottlieb CA, Clarke MF. 1993. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol Cell Biol 13:711-719.
32. Schroeter EH, Kisslinger JA, Kopan R. 1998. Notch-1 signaling requires ligand-induced proteolytic release of intracellular domain. Nature 393:382-386.
33. Shawber C, Nofziger D, Hsieh JJ, Lindsell C, Bogler O, Hayward D, Weinmaster G. 1996. Notch signaling inhibits muscle cell differentiation through a CBF1-independent pathway. Development 122:3765-3773.
34. Sherwood SW, Schimke RT. 1995. Cell cycle analysis of apoptosis using flow cytometry. In: Schwartz LM, Osborne BA, editors. Methods in cell biology, vol. 46. p 77-97.
35. Siegel DS, Zhang JX, Feinman R, Teitz T, Zelenetz A, Richon VM, Rifkind RA, Marks PA, Michaeli J. 1998. Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates BCL-2 expression in human myeloma cells. Proc Natl Acad Sci USA 95:162-166.
36. Struhl G, Adachi A. 1998. Nuclear access and action of notch in vivo. Cell 93:649-660.
37. Washburn T, Schweighoffer E, Gridley T, Chang D, Fowlkes BJ, Cado D, Robey E. 1997. Notch activity influences the alphabeta versus gammadelta T cell lineage decision. Cell 88:833-843.
38. Weinmaster G. 1997. The ins and outs of notch signaling. Mol Cell Neurosci 9:91-102.
39. Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML, Artavanis-Tsakonas S. 1995. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci USA 92:6414-6418.
40. Zhuo S, Fan S, Huang S, Kaufman S. 1995. Study of the role of retinoblastoma protein in terminal differentiation of murine erythroleukemia cells. Proc Natl Acad Sci USA 92:4234-4238.